TS Financial Group (TSFG)’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-292
Closed -$2K 1052
2022
Q3
$2K Hold
292
﹤0.01% 842
2022
Q2
$2K Hold
292
﹤0.01% 855
2022
Q1
$2K Hold
292
﹤0.01% 826
2021
Q4
$1K Hold
292
﹤0.01% 875
2021
Q3
$2K Hold
292
﹤0.01% 779
2021
Q2
$2K Buy
+292
New +$2.01K ﹤0.01% 773

Other funds holding AVEO

TS Financial Group (TSFG)'s AVEO Position: Q4 2022 in Review

TS Financial Group (TSFG) sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2022, closing a stake of 292 shares — an estimated $2K sold.

TS Financial Group (TSFG) first reported a position in AVEO in Q2 2021 and held it in 6 quarters. The position peaked at $2K in Q3 2022. 110 funds tracked by Wall St. Rank hold AVEO as of Q4 2022.

  • TS Financial Group (TSFG) reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 292 AVEO Pharmaceuticals, Inc. shares in Q4 2022, an estimated $2K.
  • TS Financial Group (TSFG) first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2021 and held it in 6 quarters.
  • TS Financial Group (TSFG)'s AVEO Pharmaceuticals, Inc. position peaked at $2K in Q3 2022.
  • 110 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2022.

Based on TS Financial Group (TSFG)'s 13F filing for Q4 2022, filed 19 Jan 2023.